{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:21:40Z","timestamp":1781839300406,"version":"3.54.5"},"reference-count":85,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease is a pathology with a wide range of <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> models available. Among these, the SH-SY5Y neuroblastoma cell line is one of the most employed. This model expresses catecholaminergic markers and can differentiate and acquire various neuronal phenotypes. However, challenges persist, primarily concerning the variability of growth media, expression of dopaminergic markers, and a wide variety of differentiation protocols have been reported in the literature without direct comparison between them. This lack of standardized differentiation conditions impacts result reproducibility and it makes it very difficult to compare the results obtained from different research groups. An alternative cellular model is the neuroblastoma BE (2)-M17 which exhibits a high basal expression of numerous dopaminergic markers such as tyrosine hydroxylase (TH), vesicular monoamine transporter 2 (VMAT2), and dopamine transporter (DAT). The BE (2)-M17 cells show neuronal properties, grows rapidly in conventional media, and can easily be differentiated to increase their dopaminergic phenotype. In this review, we will thoroughly explore the properties of the BE (2)-M17 cell line and discuss its potential as an excellent model for studying Parkinson\u2019s disease.<\/jats:p>","DOI":"10.3389\/fncel.2024.1485414","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T04:25:06Z","timestamp":1732595106000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The BE (2)-M17 neuroblastoma cell line: revealing its potential as a cellular model for Parkinson\u2019s disease"],"prefix":"10.3389","volume":"18","author":[{"given":"Angel","family":"Carvajal-Oliveros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Rom\u00e1n-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-14-49","article-title":"Morphological and functional differentiation in BE(2)-M17 human neuroblastoma cells by treatment with Trans-retinoic acid.","volume":"14","author":"Andres","year":"2013","journal-title":"BMC Neurosci."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050262","article-title":"Sensitivity to lysosome-dependent cell death is directly regulated by lysosomal cholesterol content.","volume":"7","author":"Appelqvist","year":"2012","journal-title":"PLoS One"},{"key":"B3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: A review.","volume":"323","author":"Armstrong","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.683459","article-title":"The ageing brain: Molecular and cellular basis of neurodegeneration.","volume":"9","author":"Azam","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/mds.23878","article-title":"Projected numbers of people with movement disorders in the years 2030 and 2050.","volume":"26","author":"Bach","year":"2011","journal-title":"Movement Disord."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020551","article-title":"The neuroprotective effects of cinnamic aldehyde in an MPTP mouse model of parkinson\u2019s disease.","volume":"19","author":"Bae","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-11-41","article-title":"\u03b1-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells.","volume":"11","author":"Bisaglia","year":"2010","journal-title":"BMC Neurosci."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00080","article-title":"Mechanisms of \u03b1-Synuclein induced synaptopathy in Parkinson\u2019s disease.","volume":"12","author":"Bridi","year":"2018","journal-title":"Front. Neurosci."},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction.","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0282348","article-title":"Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment.","volume":"18","author":"Carvajal-Oliveros","year":"2023","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88910-4","article-title":"Nicotine suppresses Parkinson\u2019s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels.","volume":"11","author":"Carvajal-Oliveros","year":"2021","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ibneur.2022.11.007","article-title":"The BE (2)-M17 cell line has a better dopaminergic phenotype than the traditionally used for Parkinson\u2019s research SH-SY5Y, which is mostly serotonergic.","volume":"13","author":"Carvajal-Oliveros","year":"2022","journal-title":"IBRO Neurosci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/bbrc.1993.1199","article-title":"Modulation of a novel thermolysin-like metallo-endopeptidase activity during retinoic acid-induced differentiation of human neuroectodermal tumor cell lines.","volume":"191","author":"Carvalho","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"8314","DOI":"10.1523\/JNEUROSCI.1972-07.2007","article-title":"An endogenous serine\/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson\u2019s disease.","volume":"27","author":"Chee","year":"2007","journal-title":"J. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/jcmm.17148","article-title":"Cinnamic Aldehyde, the main monomer component of Cinnamon, exhibits anti-inflammatory property in OA synovial fibroblasts via TLR4\/MyD88 pathway.","volume":"26","author":"Chen","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1093\/brain\/awad064","article-title":"Impaired dopamine release in Parkinson\u2019s disease.","volume":"146","author":"Cramb","year":"2023","journal-title":"Brain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1210\/en.2013-2158","article-title":"Transient neuroprotection by SRY upregulation in dopamine cells following injury in males.","volume":"155","author":"Czech","year":"2014","journal-title":"Endocrinology"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcz016","article-title":"To be or not to be pink(1): Contradictory findings in an animal model for Parkinson\u2019s disease.","volume":"1","author":"De Haas","year":"2019","journal-title":"Brain Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson\u2019s disease.","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12017-017-8448-8","article-title":"Individual amino acid supplementation can improve energy metabolism and decrease ROS production in neuronal cells overexpressing Alpha-synuclein.","volume":"19","author":"Delic","year":"2017","journal-title":"NeuroMol. Med."},{"key":"B21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1005745717231","article-title":"Expression and retinoid modulation of N-arginine dibasic convertase and an aminopeptidase-B in human neuroblastoma cell lines.","volume":"31","author":"Draoui","year":"1997","journal-title":"J. Neuroncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.2010.05906.x","article-title":"VMAT2: A dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse.","volume":"1216","author":"Eiden","year":"2011","journal-title":"Ann. N Y Acad. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1515\/jbcpp-2019-0270","article-title":"6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels.","volume":"32","author":"Elyasi","year":"2021","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejcb.2017.01.002","article-title":"Impact of high cholesterol in a Parkinson\u2019s disease model: Prevention of lysosomal leakage versus stimulation of \u03b1-synuclein aggregation.","volume":"96","author":"Eriksson","year":"2017","journal-title":"Eur. J. Cell Biol."},{"key":"B25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/jnc.13618","article-title":"Cellular models for Parkinson\u2019s disease.","volume":"139","author":"Falkenburger","year":"2016","journal-title":"J. Neurochem."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136769","article-title":"Analysis of the catecholaminergic phenotype in human SH-SY5Y and BE(2)-M17 neuroblastoma cell lines upon differentiation.","volume":"10","author":"Filograna","year":"2015","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1146\/annurev.pharmtox.40.1.617","article-title":"14-3-3 Proteins: Structure, function, and regulation.","volume":"40","author":"Fu","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/dmm.030205","article-title":"Neurodegenerative disease: Models, mechanisms, and a new hope.","volume":"10","author":"Gitler","year":"2017","journal-title":"Dis. Models Mechanisms"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01251-0","article-title":"Aging and aging-related diseases: From molecular mechanisms to interventions and treatments.","volume":"7","author":"Guo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/srep45465","article-title":"Mechanistic investigations of the mitochondrial complex i inhibitor rotenone in the context of pharmacological and safety evaluation.","volume":"7","author":"Heinz","year":"2017","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.nrleng.2015.06.019","article-title":"The 6-hydroxydopamine model and parkinsonian pathophysiology: Novel findings in an older model.","volume":"32","author":"Hernandez-Baltazar","year":"2017","journal-title":"Neurolog\u00eda"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73854-y","article-title":"Characterization of a Cul9\u2013Parkin double knockout mouse model for Parkinson\u2019s disease.","volume":"10","author":"Hollville","year":"2020","journal-title":"Sci. Rep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","article-title":"Rotenone-induced model of Parkinson\u2019s disease: Beyond mitochondrial complex I inhibition.","volume":"60","author":"Ibarra-Guti\u00e9rrez","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.tiv.2019.06.019","article-title":"In vitro 6-hydroxydopamine-induced neurotoxicity: New insights on NF\u03baB modulation.","volume":"60","author":"Iglesias Gonz\u00e1lez","year":"2019","journal-title":"Toxicol. Vitro"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2201020","article-title":"SH-SY5Y cell line in vitro models for Parkinson disease research-old practice for new trends.","volume":"22","author":"Ioghen","year":"2023","journal-title":"J. Integr. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2017.00335","article-title":"Age-related diseases and clinical and public health implications for the 85 years old and over population.","volume":"5","author":"Jaul","year":"2017","journal-title":"Front. Public Health"},{"key":"B37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s13577-014-0096-9","article-title":"Identification of cross-contamination in SH-SY5Y cell line.","volume":"27","author":"Jiang","year":"2014","journal-title":"Hum. Cell"},{"key":"B38","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nm.2224","article-title":"The benefits and limitations of animal models for translational research in neurodegenerative diseases.","volume":"16","author":"Jucker","year":"2010","journal-title":"Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"12248","DOI":"10.1523\/JNEUROSCI.1345-14.2015","article-title":"Oxytocin regulates stress-induced Crf gene transcription through creb-regulated transcription coactivator 3.","volume":"35","author":"Jurek","year":"2015","journal-title":"J. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/j.1365-2826.1995.tb00782.x","article-title":"Regulation of corticotropin-releasing factor secretion and synthesis in the human neuroblastoma clones- BE(2)-M17 and BE(2)-C.","volume":"7","author":"Kasckow","year":"1995","journal-title":"J. Neuroendocrinol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0006-8993(94)91583-0","article-title":"The BE (2)-M17 neuroblastoma cell line synthesizes and secretes corticotropin-releasing factor.","volume":"654","author":"Kasckow","year":"1994","journal-title":"Brain Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/jnen\/61.3.245","article-title":"14-3-3 proteins in lewy bodies in parkinson disease and diffuse lewy body disease brains.","volume":"61","author":"Kawamoto","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.14336\/AD.2020.0331","article-title":"Comprehensive perspectives on experimental models for Parkinson\u2019s disease.","volume":"12","author":"Ke","year":"2021","journal-title":"Aging Dis."},{"key":"B44","first-page":"83","article-title":"Animal models of parkinson\u2019s disease","author":"Konnova","year":"2018","journal-title":"Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-1-62703-640-5_2","article-title":"Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology.","volume":"1078","author":"Kovalevich","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031851","article-title":"A review of the common neurodegenerative disorders: Current therapeutic approaches and the potential role of nanotherapeutics.","volume":"23","author":"Lamptey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41527-0","article-title":"Carfilzomib enhances cisplatin-induced apoptosis in SK-N-BE(2)-M17 human neuroblastoma cells.","volume":"9","author":"Lee","year":"2019","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuroscience.2015.07.082","article-title":"The Streptomyces metabolite anhydroexfoliamycin ameliorates hallmarks of Alzheimer\u2019s disease in vitro and in vivo.","volume":"305","author":"Leir\u00f3s","year":"2015","journal-title":"Neuroscience"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-024-00236-3","article-title":"Targeting Mitochondrial complex I deficiency in MPP+\/MPTP-induced Parkinson\u2019s disease cell culture and mouse models by transducing yeast NDI1 gene.","volume":"26","author":"Li","year":"2024","journal-title":"Biol. Proc. Online"},{"key":"B50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/toxsci\/kfw106","article-title":"Vesicular monoamine transporter 2 (VMAT2) level regulates MPTP vulnerability and clearance of excess dopamine in mouse striatal terminals.","volume":"153","author":"Lohr","year":"2016","journal-title":"Toxicol. Sci."},{"key":"B51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2022.07.008","article-title":"The SH-SY5Y human neuroblastoma cell line, a relevant in vitro cell model for investigating neurotoxicology in human: Focus on organic pollutants.","volume":"92","author":"Lopez-Suarez","year":"2022","journal-title":"NeuroToxicology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jneumeth.2013.11.024","article-title":"A cellular model of amyloid precursor protein processing and amyloid-\u03b2 peptide production.","volume":"223","author":"Macias","year":"2014","journal-title":"J. Neurosci. Methods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1046\/j.1471-4159.2003.02013.x","article-title":"Fe(II)-induced DNA damage in \u03b1\u2212synuclein-transfected human dopaminergic BE(2)-M17 neuroblastoma cells: Detection by the comet assay.","volume":"87","author":"Martin","year":"2003","journal-title":"J. Neurochem."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2021.114","article-title":"Life expectancy, healthy life expectancy, and burden of disease in older people in the Americas, 1990\u20132019: A population-based study.","volume":"45","author":"Martinez","year":"2021","journal-title":"Pan Am. J. Public Health"},{"key":"B55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0304-3940(93)90017-F","article-title":"Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: Retinoic acid may induce IGF-2.","volume":"1","author":"Melino","year":"1993","journal-title":"Neuroscr. Lett."},{"key":"B56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0047-6374(86)90118-1","article-title":"Culture media variation as related to in vitro aging of human fibroblasts: I. Effects on population doubling, nuclear volume and nuclear morphology.","volume":"37","author":"Mukherjee","year":"1986","journal-title":"Mechanisms Ageing Dev."},{"key":"B57","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jjco\/hyx176","article-title":"Neuroblastoma.","volume":"48","author":"Nakagawara","year":"2018","journal-title":"Jap. J. Clin. Oncol."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25032","article-title":"An overview of Parkinson\u2019s disease: Curcumin as a possible alternative treatment.","volume":"14","author":"Patel","year":"2022","journal-title":"Cureus"},{"key":"B59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ijc.2910520220","article-title":"Phenotype-specific \u201ctissue\u201d transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis.","volume":"52","author":"Piacentini","year":"1992","journal-title":"Int. J. Cancer"},{"key":"B60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13311-022-01332-6","article-title":"Overexpression-induced \u03b1-synuclein brain spreading.","volume":"20","author":"Pinto-Costa","year":"2023","journal-title":"Neurotherapeutics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease.","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009308","article-title":"Modeling Parkinson\u2019s disease in primates: The MPTP model.","volume":"2","author":"Porras","year":"2012","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122467","article-title":"Association between heavy metal exposure and Parkinson\u2019s disease: A review of the mechanisms related to oxidative stress.","volume":"11","author":"Pyatha","year":"2022","journal-title":"Antioxidants"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.602697","article-title":"Caffeine and Parkinson\u2019s disease: Multiple benefits and emerging mechanisms.","volume":"14","author":"Ren","year":"2020","journal-title":"Front. Neurosci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/978-1-4614-5836-4_16","article-title":"Mechanisms of dopamine oxidation and Parkinson\u2019s disease","author":"Segura-Aguilar","year":"2014","journal-title":"Handbook of Neurotoxicity"},{"key":"B66","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-Hydroxydopamine model of parkinson\u2019s disease.","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotoxicity Res."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00328","article-title":"In vitro models of neurodegenerative diseases.","volume":"8","author":"Slanzi","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B68","first-page":"633","article-title":"Regulatory role of insulin on endogenous L1 ORF1 and NEFM gene expression through PI3K signaling pathway specifically in neuroblastoma cell line.","volume":"52","author":"Sohrabi","year":"2023","journal-title":"Iran J. Public Health"},{"key":"B69","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0143-4179(92)90009-L","article-title":"Interleukin-6 and corticotrophin-releasing hormone mRNA are modulated during differentiation of human neuroblastoma cells.","volume":"23","author":"Stephanou","year":"1992","journal-title":"Neuropeptides"},{"key":"B70","doi-asserted-by":"publisher","first-page":"11401","DOI":"10.1002\/jcp.27774","article-title":"Small molecule of sphingosine as a rescue of dopaminergic cells: A cell therapy approach in neurodegenerative diseases therapeutics.","volume":"234","author":"Tavakol","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/124165","article-title":"VMAT2-deficient mice display nigral and extranigral pathology and motor and nonmotor symptoms of Parkinson\u2019s disease.","volume":"2011","author":"Taylor","year":"2011","journal-title":"Parkinson\u2019s Dis."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-017-0491-x","article-title":"Paraquat and Parkinson\u2019s disease: A systematic review protocol according to the OHAT approach for hazard identification.","volume":"6","author":"Vaccari","year":"2017","journal-title":"Syst. Rev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1593\/neo.04310","article-title":"Characteristics of stem cells from human neuroblastoma cell lines and in tumors.","volume":"6","author":"Walton","year":"2004","journal-title":"Neoplasia"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1038\/s41386-024-01914-2","article-title":"Tricyclic and tetracyclic antidepressants upregulate VMAT2 activity and rescue disease-causing VMAT2 variants.","volume":"49","author":"Wang","year":"2024","journal-title":"Neuropsychopharmacology"},{"key":"B75","year":"2023","journal-title":"Number of people living with brain disease expected to double by 2050"},{"key":"B76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10616-009-9200-5","article-title":"Effects of DMEM and RPMI 1640 on the biological behavior of dog periosteum-derived cells.","volume":"59","author":"Wu","year":"2009","journal-title":"Cytotechnology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0149-0","article-title":"The SH-SY5Y cell line in Parkinson\u2019s disease research: A systematic review.","volume":"12","author":"Xicoy","year":"2017","journal-title":"Mol. Neurodegeneration"},{"key":"B78","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3109\/10408444.2012.680431","article-title":"Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson\u2019s disease models.","volume":"42","author":"Xiong","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"B79","first-page":"163","author":"Xiong","year":"2017","journal-title":"Models of LRRK2-Associated Parkinson\u2019s Disease"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2009.4","article-title":"Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson\u2019s disease.","volume":"1","author":"Yacoubian","year":"2010","journal-title":"Cell Death Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"8061","DOI":"10.18632\/aging.204954","article-title":"Coumarin-chalcone hybrid LM-021 and indole derivative NC009-1 targeting inflammation and oxidative stress to protect BE(2)-M17 cells against \u03b1-synuclein toxicity.","volume":"15","author":"Yang","year":"2023","journal-title":"Aging"},{"key":"B82","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis","article-title":"Genetics and pathogenesis of Parkinson\u2019s syndrome.","volume":"18","author":"Ye","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2022.167775","article-title":"The role of \u03b1-Synuclein in SNARE-mediated synaptic vesicle fusion.","volume":"435","author":"Yoo","year":"2023","journal-title":"J. Mol. Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1210\/en.2005-1222","article-title":"Identification of a functional AP1 element in the rat vasopressin gene promoter.","volume":"147","author":"Yoshida","year":"2006","journal-title":"Endocrinology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00705-010-0644-x","article-title":"Protection against HIV-envelope-induced neuronal cell destruction by HIV attachment inhibitors.","volume":"155","author":"Zhang","year":"2010","journal-title":"Arch. Virol."}],"container-title":["Frontiers in Cellular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2024.1485414\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T04:25:16Z","timestamp":1732595116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fncel.2024.1485414\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":85,"alternative-id":["10.3389\/fncel.2024.1485414"],"URL":"https:\/\/doi.org\/10.3389\/fncel.2024.1485414","relation":{},"ISSN":["1662-5102"],"issn-type":[{"value":"1662-5102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"article-number":"1485414"}}